Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 28, 2017; 23(16): 2826-2831
Published online Apr 28, 2017. doi: 10.3748/wjg.v23.i16.2826
Published online Apr 28, 2017. doi: 10.3748/wjg.v23.i16.2826
2003 survey | 2007 survey | 2011 survey | P value | |
Antibiotics (Total AP) | ||||
Carbapenem | 280 (27.7) | 327 (32.5) | 689 (36.9) | < 0.00011 |
Cephem | 270 (26.7) | 264 (26.2) | 485 (26.0) | |
Cephem/β-lactamase inhibitor combination | 429 (42.4) | 390 (38.8) | 641 (34.4) | |
Others | 33 (3.2) | 25 (2.5) | 51 (2.7) | |
Antibiotics (Severe AP) | ||||
Carbapenem | 86 (41.2) | 107 (52.2) | 286 (67.3) | < 0.00011 |
Cephem | 54 (25.8) | 36 (17.6) | 48 (11.3) | |
Cephem/β-lactamase inhibitor combination | 62 (29.7) | 57 (27.8) | 80 (18.8) | |
Others | 7 (3.3) | 5 (2.4) | 11 (2.6) |
- Citation: Hamada S, Masamune A, Shimosegawa T. Transition of early-phase treatment for acute pancreatitis: An analysis of nationwide epidemiological survey. World J Gastroenterol 2017; 23(16): 2826-2831
- URL: https://www.wjgnet.com/1007-9327/full/v23/i16/2826.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i16.2826